Indivior Pharmaceuticals Inc (INDV)

Panoramica Notizia Cronologia dei prezzi Forum Previsione

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Indivior Pharmaceuticals Inc Stock (INDV) Company Profile

Indivior Pharmaceuticals Inc

Healthcare (1096)

804-379-1090

10710 MIDLOTHIAN TURNPIKE, NORTH CHESTERFIELD

Prossima data di guadagno

Ultimi documenti SEC

INDV's Discussions on Twitter

Compare INDV vs TAK, HLN, TEVA, ZTS, UTHR

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
INDV Indivior Pharmaceuticals Inc	41.83	4.94B	1.29B	251.00M	-193.86M	1.9744
TAK Takeda Pharmaceutical Co Adr	15.91	50.27B	29.91B	1.30B	3.49B	0.4056
HLN Haleon Plc Adr	9.24	40.72B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	33.21	38.67B	17.53B	1.58B	444.18M	1.3457
ZTS Zoetis Inc	76.09	31.90B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	542.66	23.03B	3.17B	1.29B	1.01B	27.09

Indivior Pharmaceuticals Inc Stock (INDV) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-08-06	Iniziato	H.C. Wainwright	Buy
2025-07-22	Ripresa	Jefferies	Buy
2025-01-28	Iniziato	Rodman & Renshaw	Buy
2024-07-23	Iniziato	Piper Sandler	Overweight
2024-04-03	Iniziato	Craig Hallum	Buy
2023-07-13	Iniziato	Northland Capital	Outperform

Mostra tutto

Indivior Pharmaceuticals Inc Borsa (INDV) Ultime notizie

Indivior Pharmaceuticals Inc Azioni (INDV) Dati Finanziari

Indivior Pharmaceuticals Inc (INDV)

Indivior Pharmaceuticals Inc Stock (INDV) Company Profile

Compare INDV vs TAK, HLN, TEVA, ZTS, UTHR

Indivior Pharmaceuticals Inc Stock (INDV) Upgrades & Downgrades

Indivior Pharmaceuticals Inc Borsa (INDV) Ultime notizie

Indivior consensus shapes expectations, shares on Nasdaq under analyst scrutiny - Ad-hoc-news.de

INDV Forecast — Price Target — Prediction for 2027 - TradingView

Enterprise value to revenue forward of Indivior Pharmaceuticals, Inc. – NASDAQ:INDV - TradingView

Price to book forward of Indivior Pharmaceuticals, Inc. – NASDAQ:INDV - TradingView

Enterprise value to revenue forward of Indivior Pharmaceuticals, Inc. – BMV:INDV1 - TradingView

Price to sales forward of Indivior Pharmaceuticals, Inc. – NASDAQ:INDV - TradingView

Price to book forward of Indivior Pharmaceuticals, Inc. – BMV:INDV1 - TradingView

Price to sales forward of Indivior Pharmaceuticals, Inc. – BMV:INDV1 - TradingView

Enterprise value to EBITDA forward of Indivior Pharmaceuticals, Inc. – BMV:INDV1 - TradingView

Zacks Industry Outlook Indivior, Aurinia, Ironwood, Altimmune and Marker - The Globe and Mail

Indivior Pharmaceuticals, Inc. Actuals & Estimates (LS:A42086) - TradingView

Indivior Pharmaceuticals, Inc. Actuals & Estimates (NASDAQ:INDV) - TradingView

Is Big Pharma's Patent Cliff Driving a New M&A Wave - Kavout | AI

Price to earnings forward of Indivior Pharmaceuticals, Inc. – BMV:INDV1 - TradingView

E7P Forecast — Price Target — Prediction for 2027 - TradingView

IBD 50 stock Indivior breaks out amid big fund ownership expansion, strong profit prospects - MSN

Reasons Why Investors Should Consider Betting on Indivior Stock - The Globe and Mail

A42086 Forecast — Price Target — Prediction for 2027 - TradingView

Form 4 Indivior PLC For: 23 June By Investing.com - Investing.com Australia

Indivior Pharmaceuticals (INDV) CEO vests 1.27M shares, 612K for taxes - Stock Titan

Indivior gains new overweight at Barclays on business turnaround - MSN

Does Indivior Pharmaceuticals Inc. (INDV) have the potential to rally 32.48% as Wall Street analysts expect? - MSN

Indivior (INDV) 10K Form and Latest SEC Filings 2026 - MarketBeat

Indivior Pharmaceuticals (INDV) Stock Could Be 23% Undervalued As Cost Cut Narrative Builds - Sahm

INDV News | INDIVIOR PHARMACEUTICALS INC (NASDAQ:INDV) - ChartMill

INDIVIOR PHARMACEUTICALS INC (INDV) Stock Chart - ChartMill

Indivior stock gains new Overweight at Barclays (INDV:NASDAQ) - Seeking Alpha

Barclays Initiates Indivior at Overweight With $46 Price Target - marketscreener.com

Indivior PLC (INDV) Institutional Confidence - TradingKey

Indivior PLC (INDV) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

How Investors Are Reacting To Indivior (INDV) Upgraded 2026 Outlook And $175 Million Buyback Plan - Yahoo Finance

How Strong SUBLOCADE Uptake And A $175M Buyback At Indivior (INDV) Has Changed Its Investment Story - Sahm

Suboxone Tooth Decay Lawsuit Updates for 2026 - Lawsuit Information Center

Indivior's Chief Scientific Officer Sold Over 18,000 Company Shares. Should Investors Worry? - Yahoo Finance

Is Indivior Pharmaceuticals, Inc. (INDV) A Good Stock To Buy Now? - Insider Monkey

Recent price trend in Indivior Pharmaceuticals Inc. (INDV) is your friend, here's why - MSN

Indivior Pharmaceuticals Inc (INDV) Insider Sell: Christian Heid - GuruFocus

Indivior (INDV) Chief Scientific Officer sells 18,586 shares under 10b5-1 plan - Stock Titan

INDV Stock: What Sublocade Growth Signals for 2026 - The Globe and Mail

INDV and the Shift to Long-Acting Opioid Use Disorder Care in 2026 - Yahoo Finance

Is Indivior Stock a Buy After Higher 2026 Guidance? - Yahoo Finance

Immunovant Stock Gains 12.4% in a Month: What's Driving It? - TradingView

GSK's Momelotinib Gets Orphan Tag for Rare Hemato-Inflammatory Disorder - TradingView

Indivior Pharmaceuticals Inc. (INDV) is a great momentum stock: Should you buy? - MSN

HROW Stock Rises on Relaunch of Ophthalmology Drug Verkazia in the US - The Globe and Mail

[144] Indivior Pharmaceuticals, Inc. SEC Filing - Stock Titan

A Look At Indivior Pharmaceuticals (INDV) Valuation After Strong Multi Period Share Price Gains - Yahoo Finance

Indivior CFO Ryan Preblick sells $1.36m in company stock By Investing.com - Investing.com Australia

Indivior Pharmaceuticals Inc (INDV) CFO Ryan Preblick Sells 36,0 - GuruFocus

Sanofi Ends Late-Stage Study on Neurology Drug Over Weak Results - TradingView

Indivior CFO Ryan Preblick sells $1.36m in company stock - Investing.com

Indivior Pharmaceuticals Inc Azioni (INDV) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a INDV